Dr. Anita Kinney has been an actively funded investigator in the area of cancer prevention and control for over 25 years with a focus on behavioral, ethical, social, and care delivery genetics research. Her research brings a combination of behavioral science, clinical, and epidemiologic perspectives to address unsolved cancer prevention and control problems in diverse populations and settings. Her overarching research goal is to understand variation in cancer risk, determinants of risk and outcomes, and to use this information to develop effective interventions that facilitate informed decision-making, positive changes in health behaviors, and guideline-concordant genomic care delivery that leads to better outcomes. Much of Dr. Kinney's research has focused on documenting determinants of interest, access and use of genomic tests, and related health services in diverse populations, and using this information to better understand and address health disparities. She has also had considerable experience leading and collaborating on large community-based and population-based randomized trials that have developed and implemented effective interventions to promote cancer risk assessment and screening in average-risk and high-risk populations, and appropriate translation of genetic discoveries into clinical practice. Further, Dr. Kinney has pioneered effective culturally targeted and telehealth genetic risk communications, behavior change, and gene testing interventions in cancer survivors and their relatives. In addition, she has developed and tested effective health promotion interventions in cancer survivors incorporating genomic and other biomarkers to better understand biobehavioral mechanisms underlying intervention effects.
As a principal investigator or co-investigator, Dr. Kinney has led efforts that involved clinic-based and population-based recruitment, genetic counseling and testing interventions, internet-based interventions, biospecimen acquisition and analysis, NCORP cancer care delivery research studies, randomized controlled trials, multimodal surveys, community stakeholder engagement, the collection and management of complex data, including both quantitative and qualitative elements. Furthermore, her research has broadly integrated data from patient and provider surveys, focus groups, in-depth interviews, randomized trials, cancer registries, genetic test reports, genetic counseling sessions, cost sources, and medical records. Dr. Kinney has also had substantial leadership experiences that include: directing large multi-site transdisciplinary research teams, implementing and evaluating remote genomic risk communication and testing interventions, successfully achieving accrual and retention goals in diverse populations, producing over 135 peer-reviewed publications, mentoring and training over 50 students, postdocs and junior faculty, and building cancer behavioral science and care delivery research infrastructure.
View Dr. Kinney's research profile here.
- Associate Director for Population Science and Community Outreach at the Rutgers Cancer Institute of New Jersey
- Director, Cancer Health Equity Center of Excellence, School of Public Health and Rutgers Cancer Institute of New Jersey
- Director, ScreenNJ
Center for Cancer Health Equity
Dr. Kinney is also the Director for the Center for Cancer Health Equity.
The Center for Cancer Health Equity is a formal partnership between the Rutgers School of Public Health and the Cancer Institute of New Jersey, which will serve as a catalyst for training and education, research, community engagement, and public policy advocacy surrounding cancer health equity in one of the nation’s most ethnically and racially diverse states. The Center’s mission is to advance the achievement of equitable access, improved health care quality, and better outcomes across the cancer continuum – prevention, early detection, treatment, survivorship, and end-of-life care – through research, education and training, community engagement and outreach, and public policy advocacy. More information coming soon. Read the Strategic Plan here.
Additionally, if you are interested in becoming a Center for Cancer Health Equity member, please e-mail email@example.com
ScreenNJ — Colorectal & Lung Cancer Prevention, Education, and Screening
In partnership with the Rutgers Cancer Institute of New Jersey, the New Jersey Department of Health, and healthcare and community organizations across New Jersey, ScreenNJ aims to increase screening for colorectal and lung cancer, to reduce cancer mortality rates, to reduce disparities, and to educate New Jersey residents about the importance of cancer screening, early detection, and prevention. ScreenNJ was launched in 2017 and is funded in part by the State. The initial focus of ScreenNJ is on colorectal cancer and lung cancer, which are among the most prevalent cancers in the state. These cancers have better outcomes if detected early through proven screening methods such as low-dose computerized tomography (LDCT) scans for lung cancer and colonoscopy, FIT, and other recommended tests for colorectal cancer.
The goals of ScreenNJ are to:
- Increase screening rates for colorectal and lung cancer,
- support smoking cessation to reduce cancer risk,
- reduce colorectal and lung cancer mortality rates,
- address and reduce disparities in smoking, screening, and mortality rates in colorectal and lung cancer, and
- increase awareness for NJ residents and providers about the importance of colorectal and lung cancer screening, early detection, and prevention.
Community Outreach and Engagement
Rutgers Cancer Institute of New Jersey is committed to meeting the cancer-related needs of communities across the state of New Jersey. Through community outreach and engagement (COE), we lead, conduct and support efforts to reduce the cancer burden in New Jersey. Through partnerships with healthcare provider agencies, public health agencies, and community organizations, we increase cancer awareness and share information about cancer screening, treatment, research, and survivorship services, as well helping organizations initiate or expand outcomes-oriented, evidence-based cancer screening, education, and outreach services.
Our mission is to advance cancer health equity across the state of New Jersey, with a focus on underserved populations, through community capacity building, participatory research, advocacy, community and patient navigation, and innovative education and training. With our community partners across the state and informed by members of our Community Cancer Action Board (CCAB), together we strive to be national and global leaders in achieving cancer health equity, improving the quality of cancer care, reducing cancer burden, and improving recruitment of diverse populations to clinical trials in New Jersey and beyond.
To do this, we engage with partners – including coordinating community outreach events, sharing resources, providing healthcare provider continuing education, sharing innovative ideas and best practices, promoting and mentoring clinical practice improvements, and many other activities known to improve cancer care, reduce the cancer burden, and increase health equity.
View the Community Outreach and Engagement program pages here.